Skip to main content

Advertisement

Figure 2 | Clinical Proteomics

Figure 2

From: Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ

Figure 2

iTRAQ cyst fluid analysis on SAA4 and ASTL; relative protein levels in benign, stage IA, and stage IIIC for A) SAA4 and B) ASTL in serous ovarian cyst fluid. Both proteins showed a significant difference in expression levels between benign and malignant (stage IA and IIIC together) samples (ASTL p<0.001 and SAA4 p=0.04). When benign samples are compared to stage IA, there is still a significant difference in ASTL levels (p=0.001).

Back to article page